Standout Papers
Citation Impact
1 from Science/Nature 78 standout
Citing Papers
Changing etiology and epidemiology of hepatocellular carcinoma: Asia and worldwide
2024 Standout
Lorlatinib Versus Crizotinib in Patients With Advanced ALK -Positive Non–Small Cell Lung Cancer: 5-Year Outcomes From the Phase III CROWN Study
2024 Standout
Works of A. Dixmier being referenced
Weekly paclitaxel plus bevacizumab versus docetaxel as second or third-line treatment in advanced non-squamous non-small cell lung cancer (NSCLC): Results from the phase III study IFCT-1103 ULTIMATE.
2016
Comorbidities of COPD
2013 Standout
Author Peers
| Author | PRM | Oncology | Surgery | Physiology | Epidemiology | Last Decade | Papers | Cites |
|---|---|---|---|---|---|---|---|---|
| A. Dixmier | 423 | 61 | 15 | 113 | 71 | 23 | 506 | |
| A. Shekarriz | 16 | 313 | ||||||
| Ulas D. Bayraktar | 115 | 275 | 138 | 21 | 151 | 43 | 1.1k | |
| Shinji Soga | 4 | 24 | 3 | 7 | 12 | 15 | 404 | |
| R. Katz | 8 | 1 | 8 | 3 | 18 | 265 | ||
| Deborah Spain | 1 | 15 | 3 | 255 |
All Works
Loading papers...